RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000011.xml
PDF herunterladen
Dtsch Med Wochenschr 2008; 133(24): 1306
DOI: 10.1055/s-2008-1077259
DOI: 10.1055/s-2008-1077259
Pro & Contra | Commentary
Hypertensiologie© Georg Thieme Verlag KG Stuttgart · New York
Impfung gegen Angiotensin II - pro
Immunization against angiotensin II - proWeitere Informationen
Publikationsverlauf
Publikationsdatum:
04. Juni 2008 (online)
Schlüsselwörter
Hypertonie - Angiotensin II - Impfung
Key words
hypertension - angiotensin II - vaccination
Literatur
- 1
Ambühl P M. et al .
A vaccine for hypertension based on virus-like particles: preclinical efficacy and
phase I safety and immunogenicity.
J Hypertens.
2007;
25
63-72
MissingFormLabel
- 2
Brown M J. et al .
Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic
vaccine (PMD3117) in hypertensive subjects.
Clin Sci.
2004;
107
167-173
MissingFormLabel
- 3
MullerJE, Tofler G H, Stone P H.
Circadian variation and triggers of onset of acute cardiovascular disease.
Circulation.
1989;
79
733-743
MissingFormLabel
- 4
Tissot A C. et al .
Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood
pressure: a double-blind, randomised, placebo-controlled phase IIa study.
Lancet.
2008;
371
821-827
MissingFormLabel
Prof. Dr. Jürg Nussberger
CHUV-NES 6027, Department of Internal Medicine, Division of Angiology and Hypertension
CH-1011 Lausanne
Telefon: ++ 4121/3140-750
Fax: ++ 4121/3140-761
eMail: Juerg.Nussberger@chuv.ch